Close Menu

NEW YORK ─ Kantaro Biosciences on Monday said it has received CE marking for its COVID-SeroKlir and COVID-SeroIndex quantitative SARS-CoV-2 IgG antibody test kits, enabling their use in Europe and other regions that accept such designation.

COVID-SeroKlir is most useful in a clinical setting and COVID-SeroIndex is expected to be used for vaccine development or research, according to Kantaro, a joint venture between the Mount Sinai Health System and RenalytixAI, and a partner with Bio-Techne in the development of serology test kits for COVID-19.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.